ArticleCureus2025
Not All Ascending Weakness and Numbness Is Guillain-Barré Syndrome: A Report of Two Cases of Copper Deficiency Myelopathy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Copper deficiency can lead to progressive neurological dysfunction, but its symptoms may overlap with other myeloneuropathies, making diagnosis challenging. Clinical features are often nonspecific presentations that may result in initial consideration of alternative neurologic conditions. We present two cases in which copper deficiency was identified after an evolving clinical picture. The first is a 70-year-old woman with a history of esophageal and breast cancer, complicated by esophagectomy and jejunostomy tube feeding, who developed six months of progressive ascending sensory loss and gait instability. The second is an 85-year-old woman with chronic zinc supplementation and denture adhesive use, presenting with two weeks of ascending paresthesias and imbalance. These cases highlight the importance of considering nutritional and surgical history in the evaluation of progressive myeloneuropathy, as well as key physical examination, laboratory, and imaging findings. Clinicians should maintain a high index of suspicion for copper deficiency in patients presenting with Guillain-Barré syndrome (GBS)-like symptoms, particularly those with risk factors for malabsorption or chronic zinc exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.